Design
Review
Authors
Loading...
Should not yet alter heart failure management; leaves open fibroblast-targeted therapies pending interventional validation.
Key points are not available for this paper at this time.
Kakkar et al. (2010) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: